Universal Health AI Stock Analysis
Want to see UHS full AI Analyst Report?
Universal Health (UHS) AI Stock Analysis
Universal Health
(NYSE:UHS)
UHS scores well on valuation (low P/E) and technical trend strength (price above key moving averages with positive MACD). Financial performance is solid but held back by weaker cash conversion and a modest recent rise in leverage. The latest earnings call tempers the score due to lower-end 2026 positioning and meaningful 2027 Medicaid and exchange-related headwinds despite improving underlying operating trends.
Universal Health Key Performance Indicators (KPIs)
Segment Net Revenue BreakdownBreaks down net revenue by segment to show where money is earned and how the revenue mix is shifting; useful for identifying growth drivers, pricing power, and concentration risks if revenue depends on a few segments.
Acute care remains UHS’s revenue engine, but behavioral health is growing faster and materially narrowing the gap—shifting the company toward a more diversified, less cyclical revenue mix. The acceleration since 2024 suggests stronger volume/pricing or strategic expansion (organic openings or deals); investor focus should be on management’s cadence for new bed capacity, acquisitions, payer mix and staffing constraints, which will determine whether this mix shift drives durable margin improvement or simply revenue growth without proportional earnings leverage.
Universal Health (UHS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $9.68B
- Dividend Yield
- 0.43%
- Average Volume (3M)
- 701.53K
- Price to Earnings (P/E)
- 7.7
- Beta (1Y)
- 0.35
- Revenue Growth
- 8.00%
- EPS Growth
- 13.14%
- Country
- US
- Employees
- 102,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
Universal Health Business Overview & Revenue Model
Company Description
Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its busine...
How the Company Makes Money
UHS generates revenue primarily by providing healthcare services at its owned and operated facilities and being reimbursed by third-party payers, patients, and government programs. (1) Acute Care segment: UHS earns money from patient service revenue...
Universal Health Earnings Call Summary
The call reflected a mixed but cautiously constructive outlook. UHS reported solid acute care admissions, emergency department visits, behavioral health volumes, cash flow, labor trends, and strategic progress in outpatient access and Talkspace integration. However, these positives were offset by lower adjusted EPS and EBITDA, slower de novo hospital ramps, a decline in surgical volumes, Laurel Ridge losses, exchange-related pressure, and substantial expected Medicaid supplemental payment headwinds. Management reiterated guidance but expects 2026 results toward the lower end of the ranges, making the overall tone balanced.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
UHS reiterated its financial and operating forecast ranges issued with its second quarter results in July and currently expects results to be towards the lower end of these ranges; it expects Cedar Hill Regional Medical Center to reach operational break even in the first half of 2027, Laurel Ridge Treatment Center recertification during 2027, and facilities incurring operating losses during 2026 of $80 million-$100 million to recover at least a meaningful portion of those losses in 2027. The company estimates a 2027 Medicaid supplemental payments headwind of approximately $175 million-$200 million, including approximately $10 million during the fourth quarter 2027 from the initial provider tax portion of the OB3 funding cuts, while annualizing the second half 2026 exchange run rate would create a $15 million headwind in 2027; it has no estimate for Medicaid work requirements. UHS expects capital expenditures to be slightly below $1 billion for the full-year of 2026 and to moderate towards $800 million beyond 2026, with its acute care growth algorithm at 1.5%-2.5% adjusted admission growth and 2%-3% pricing growth and its behavioral health algorithm at 1%-2% adjusted patient day growth and 2%-3% pricing; Talkspace synergies are expected over the first 12-24 months of ownership, with the transaction expected to be slightly accretive in the first 12 months.
Universal Health Financial Statement Overview
Summary
Fundamentals are solid: steady revenue growth and durable profitability (TTM operating margin ~11.5%, EBITDA margin ~15.1%, net margin ~8%). Offsets include slightly softer margins vs. 2025, a modest uptick in leverage (debt-to-equity ~0.81 TTM), and weaker cash conversion (operating cash flow below net income across periods despite improved free cash flow).
Income Statement
78PositiveBalance Sheet
72PositiveCash Flow
66Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.35B | 17.36B | 15.83B | 14.28B | 13.40B | 12.64B |
| Gross Profit | 12.80B | 15.71B | 14.24B | 12.75B | 11.93B | 11.21B |
| EBITDA | 2.78B | 2.74B | 2.27B | 1.72B | 1.58B | 1.91B |
| Net Income | 1.46B | 1.49B | 1.14B | 717.79M | 675.61M | 991.59M |
Balance Sheet | ||||||
| Total Assets | 17.19B | 15.96B | 14.47B | 13.97B | 13.49B | 13.09B |
| Cash, Cash Equivalents and Short-Term Investments | 168.75M | 137.80M | 125.98M | 119.44M | 102.82M | 115.30M |
| Total Debt | 6.18B | 5.51B | 4.96B | 5.37B | 5.27B | 4.56B |
| Total Liabilities | 9.52B | 8.55B | 7.71B | 7.77B | 7.52B | 6.90B |
| Stockholders Equity | 7.60B | 7.28B | 6.67B | 6.15B | 5.92B | 6.09B |
Cash Flow | ||||||
| Free Cash Flow | 1.12B | 849.25M | 1.12B | 524.74M | 262.02M | 28.04M |
| Operating Cash Flow | 2.06B | 1.86B | 2.07B | 1.27B | 996.02M | 883.70M |
| Investing Cash Flow | -1.87B | -1.07B | -911.11M | -763.27M | -647.30M | -914.47M |
| Financing Cash Flow | -101.79M | -749.73M | -1.14B | -493.94M | -318.40M | -1.07B |
Universal Health Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UHS, the sentiment is Positive. The current price of 186.07 is below the 20-day moving average (MA) of 188.06, above the 50-day MA of 182.15, and above the 200-day MA of 176.12, indicating a bullish trend. The MACD of 4.28 indicates Negative momentum. The RSI at 54.74 is Neutral, neither overbought nor oversold. The STOCH value of 44.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UHS.
Universal Health Risk Analysis
Universal Health disclosed 32 risk factors in its most recent earnings report. Universal Health reported the most risks in the "Production" category.
Latest Risks Added
3 New RisksUniversal Health Peers Comparison
Overall Rating
THC87Outperform
UHS74Outperform
EHC70Outperform
HCA64Neutral
ACHC53Neutral
CYH44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 87Outperform | $22.45B | 7.82 | 60.60% | ― | 6.23% | 136.09% | |
| 74Outperform | $10.73B | 7.72 | 19.54% | 0.43% | 8.00% | 13.14% | |
| 70Outperform | $13.53B | 20.82 | 25.17% | 0.58% | 9.36% | 20.78% | |
| 64Neutral | $99.51B | 15.74 | -100.45% | 0.64% | 5.82% | 16.59% | |
| 53Neutral | $3.53B | -3.01 | -57.05% | ― | 4.47% | -1156.09% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 44Neutral | $284.87M | 6.89 | -2.51% | ― | -7.84% | -88.93% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| UHS | Universal Health Services | 186.07 | -38.33 | -17.08% | |
| ACHC | Acadia Healthcare Company, Inc. | 37.59 | 23.23 | 161.77% | |
| CYH | Community Health Systems | 1.86 | -1.08 | -36.73% | |
| HCA | Hca Healthcare | 476.35 | 3.31 | 0.70% | |
| EHC | Encompass Health | 134.93 | 22.97 | 20.52% | |
| THC | Tenet Healthcare Corp. | 271.34 | 84.66 | 45.35% |
Universal Health Corporate Events
Universal Health Completes $1.1 Billion Senior Notes Offering
PositiveOn August 20, 2026, Universal Health Services, Inc. completed a public offering of $1.1 billion in senior secured notes, issuing $600 million of 5.500% notes due 2031 and $500 million of 6.000% notes due 2036, both guaranteed on a senior secured basi...
Universal Health completes Talkspace behavioral health acquisition
PositiveOn August 17, 2026, Universal Health Services completed its acquisition of virtual behavioral health platform Talkspace, following a merger in which Talkspace became an indirect wholly owned subsidiary. UHS financed the cash purchase, including $5.25...
Universal Health Announces $1.1 Billion Senior Notes Offering
NeutralOn August 11, 2026, Universal Health Services, Inc. and certain subsidiaries entered into an underwriting agreement to issue $1.1 billion of senior secured notes, comprising $600 million of 5.500% notes due 2031 and $500 million of 6.000% notes due 2...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
